SCHEMBL7143995

SCHEMBL7143995

COc1ccc(-c2ccccc2)n2nc(NC(=O)c3cccc(Cl)c3)nc12

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 3/20 0.53
TDP2 O95551 3/20 0.52
PDE4D Q08499 5/20 0.50
ADORA2A P29274 2/20 0.49
MAPT P10636 4/20 0.48
KDM4E B2RXH2 2/20 0.48
RXFP1 Q9HBX9 2/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
GRM5 P41594 1/20 0.47
PTGS2 P35354 1/20 0.47
ADORA3 P0DMS8 1/20 0.46
ALDH1A1 P00352 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C19 P33261 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6870164 0.90 KDM4E (0.58) PDE4DMAPTKDM4ERXFP1NPC1
SCHEMBL7149095 0.89 MAPT (0.54) ADORA1PDE4DADORA2AMAPTKDM4E
SCHEMBL7146900 0.88 PDE4D (0.50) PDE4DMAPTKDM4ERXFP1NPC1
SCHEMBL7045952 0.88 TDP2 (0.52) TDP2PDE4DMAPTKDM4ERXFP1
SCHEMBL7145859 0.86 JAK2 (0.54) TDP2PDE4DMAPTKDM4EGRM5
SCHEMBL7043536 0.85 MAPT (0.48) TDP2MAPTKDM4ENPC1RAB9A
SCHEMBL7140763 0.84 MAPT (0.68) ADORA1PDE4DADORA2AMAPTKDM4E
SCHEMBL7042283 0.83 MAPT (0.56) ADORA1PDE4DADORA2AMAPTKDM4E
SCHEMBL7039193 0.83 LMNA (0.61) PDE4DMAPTKDM4ERXFP1NPC1
SCHEMBL7145323 0.83 PDE4D (0.48) ADORA1PDE4DADORA2AMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6514989-B1 Has a good affinity to the adenosine receptor and can therefore be used for the treatment or protection of diseases mediated by this receptor HOFFMANN-LA ROCHE INC. 2003-02-04 US disclosed
US-6514989-B1 Has a good affinity to the adenosine receptor and can therefore be used for the treatment or protection of diseases mediated by this receptor HOFFMANN-LA ROCHE INC. 2003-02-04 US disclosed
US-6514989-B1 Has a good affinity to the adenosine receptor and can therefore be used for the treatment or protection of diseases mediated by this receptor HOFFMANN-LA ROCHE INC. 2003-02-04 US disclosed